New Drug Can Stop Fatty Liver Disease Before It Turns Deadly: UC Scientists
Unlike many existing treatments for fatty liver disease that mainly focus on weight loss, this new experimental drug targets the disease process itself.
Unlike many existing treatments for fatty liver disease that mainly focus on weight loss, this new experimental drug targets the disease process itself.
WHO advisory groups recommend prioritizing three candidate therapeutics for Bundibugyo Ebola trials: Mapp Biopharmaceutical’s MBP134, Regeneron’s Maftivimab, and Gilead Sciences’ antiviral remdesivir.
While medications remain the first-line treatment for trigeminal neuralgia, CyberKnife-based stereotactic radiosurgery can offer significant relief when conventional therapies fail.
Biohub’s world model brings together open-source AI models — ESMC, ESMFold2, and ESM Atlas — to help researchers better understand proteins and speed up the discovery of new therapeutics.
The global CAR T-cell therapy market is projected to grow from USD 6.78 billion in 2026 to USD 13.56 billion by 2031.
The purchase of the three vaccine developers could cost Lilly up to USD 3.8 billion.
The study will initially evaluate the performance of ABILITY’s BCI as a home-use system to restore communication and speech in ALS patients.
As India targets a USD 130 billion pharmaceutical market by 2030, several key factors are expected to drive its next phase of growth.
Voy India, formerly EarlyFit, will initially focus on weight loss and obesity care before gradually expanding into broader therapeutic areas.
The proposed registry will initially focus on cardiac and orthopaedic implants and will expand gradually to include all implantable medical devices.